$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Is vorasidenib-VORANIGO an oral drug, how to use it, and patient precautions when taking the drug
2026-02-01 22:25:32
Check Details
Summary and analysis of the efficacy and clinical research of Zongatinib (Zongatinib) in patients with HER2 exon20 mutations
2026-02-01 22:25:32
Check Details
Summary and analysis of vosoritide clinical trial data and different indications, efficacy observations and safety studies
2026-02-01 22:25:32
Check Details
The main components of Methylcobalamin Injection (Rozebalamin) and its principle of promoting nerve regeneration
2026-02-01 22:25:32
Check Details
Analysis of the scope of indications and latest clinical applications of the anticancer drug cobimetinib
2026-02-01 22:25:32
Check Details
How effective is macitentan (Aoposu) in treating pulmonary arterial hypertension? Analysis of the latest clinical data
2026-02-01 22:25:32
Check Details
Which type of acute myeloid leukemia is Avonib (Tosovo) mainly used to treat?
2026-02-01 22:25:32
Check Details
Which formal channels can you buy Mitotane tablets in China?
2026-02-01 22:25:32
Check Details
Can I stop taking Pemetinib (Dabotan) at will once I start taking it?
2026-02-01 22:25:32
Check Details
Which formal channels can safely purchase Erdafitinib in China?
2026-02-01 22:25:32
Check Details
Analysis of whether Erlotinib is domestically produced or imported original drug and version differences
2026-02-01 22:25:32
Check Details
Is tofacitinib (Shangjie) available in a cream formulation and a version for external use on skin?
2026-02-01 22:25:32
Check Details
1
2
...
2424
2425
2426
2427
2428
2429
2430
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma